CA Stock MarketDetailed Quotes

NGEN NervGen Pharma Corp

Watchlist
  • 2.690
  • -0.050-1.82%
15min DelayMarket Closed Jun 28 16:00 ET
188.11MMarket Cap-7911P/E (TTM)

NervGen Pharma Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
32.09%-3.25M
36.49%-11.3M
38.93%-3.09M
70.28%-1.43M
45.90%-2M
-13.11%-4.78M
-115.07%-17.78M
-76.92%-5.05M
-138.56%-4.81M
-75.10%-3.69M
Net income from continuing operations
50.19%-2.35M
-8.01%-22.38M
-44.92%-8.61M
-23.07%-4.3M
24.63%-4.76M
5.20%-4.71M
-62.83%-20.72M
-43.25%-5.94M
2.87%-3.5M
-131.20%-6.32M
Operating gains losses
-1,483.48%-2.27M
297.34%5.12M
628.50%3.79M
153.44%1.02M
285.75%142.6K
4,273.79%164.03K
-8,172.95%-2.6M
-1,480.34%-718.02K
-1,808.66%-1.91M
516.62%36.97K
Depreciation and amortization
10.22%38.31K
25.96%145K
11.13%38.62K
5.39%36.63K
2.27%35K
205.29%34.75K
170.06%115.11K
210.14%34.75K
219.83%34.75K
223.74%34.22K
Remuneration paid in stock
56.28%1.15M
117.83%6.04M
159.18%1.39M
187.55%1.75M
160.24%2.16M
-7.57%736.78K
-30.90%2.77M
-50.10%537.12K
-53.66%609.53K
-1.97%831.2K
Other non cashItems
-31.37%2.85K
-97.23%14.66K
-28.72%3.18K
-99.32%3.51K
--3.83K
--4.15K
--528.9K
--4.46K
--519.37K
----
Change In working capital
117.27%174.85K
-111.36%-240.35K
-71.45%293.54K
110.47%59.23K
-75.59%419.1K
-1,473.59%-1.01M
391.28%2.11M
581.31%1.03M
-258.25%-565.63K
857.90%1.72M
-Change in receivables
474.63%236.63K
-703.60%-223.18K
-43,531.54%-226.88K
-76.13%16.78K
285.95%50.08K
-975.86%-63.16K
2,726.07%36.98K
97.64%-520
326.22%70.3K
-4.02%-26.93K
-Change in prepaid assets
-145.94%-170.85K
123.65%57.32K
166.31%182.21K
-407.73%-159.67K
-519.63%-337.15K
472.82%371.94K
-314.12%-242.33K
-259.54%-274.8K
-71.39%51.89K
80.75%80.35K
-Change in payables and accrued expense
108.26%109.07K
-103.21%-74.49K
-74.05%338.21K
129.39%202.12K
-57.54%706.17K
-3,297.88%-1.32M
627.98%2.32M
186,121.57%1.3M
-530.99%-687.81K
778.72%1.66M
Cash from discontinued investing activities
Operating cash flow
32.09%-3.25M
36.49%-11.3M
38.93%-3.09M
70.28%-1.43M
45.90%-2M
-13.11%-4.78M
-115.07%-17.78M
-76.92%-5.05M
-138.56%-4.81M
-75.10%-3.69M
Investing cash flow
Cash flow from continuing investing activities
0
-557.92%-138.85K
1
-2,320.19%-138.46K
70.54%-2.94K
147.27%2.55K
53.19%-21.11K
0
-108.04%-5.72K
76.39%-9.99K
Net PPE purchase and sale
--0
85.43%-3.07K
--1
53.17%-2.68K
70.54%-2.94K
147.27%2.55K
-667.73%-21.11K
--0
-108.04%-5.72K
---9.99K
Net intangibles purchas and sale
----
---135.78K
--0
----
----
----
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
--0
-557.92%-138.85K
--1
-2,320.19%-138.46K
70.54%-2.94K
147.27%2.55K
53.19%-21.11K
--0
-108.04%-5.72K
76.39%-9.99K
Financing cash flow
Cash flow from continuing financing activities
5,924.01%22M
-96.62%766.29K
-6.16%74.77K
-99.64%72.38K
-90.09%253.86K
184.63%365.27K
15.44%22.64M
-99.31%79.68K
607.61%19.87M
-43.26%2.56M
Net issuance payments of debt
0.00%-25.23K
-33.33%-100.93K
0.00%-25.23K
-0.00%-25.23K
0.00%-25.23K
---25.23K
---75.7K
---25.23K
---25.23K
---25.23K
Net common stock issuance
--23.01M
--0
--0
----
----
--0
4.56%19.76M
-99.06%108.35K
----
----
Proceeds from stock option exercised by employees
58.89%620.46K
-71.87%867.21K
-20.38%100K
-58.51%97.61K
-89.24%279.09K
204.29%390.51K
29.67%3.08M
-87.89%125.6K
-63.23%235.3K
--2.59M
Net other financing activities
---1.6M
----
----
----
----
----
92.26%-129.04K
----
----
----
Cash from discontinued financing activities
Financing cash flow
5,924.01%22M
-96.62%766.29K
-6.16%74.77K
-99.64%72.38K
-90.09%253.86K
184.63%365.27K
15.44%22.64M
-99.31%79.68K
607.61%19.87M
-43.26%2.56M
Net cash flow
Beginning cash position
-48.07%11.66M
32.62%22.45M
-46.62%14.79M
38.06%16.08M
40.48%18.02M
32.62%22.45M
202.38%16.93M
235.78%27.7M
58.29%11.65M
157.25%12.83M
Current changes in cash
524.97%18.76M
-320.59%-10.67M
39.46%-3.01M
-109.93%-1.5M
-53.06%-1.75M
-7.54%-4.41M
-57.20%4.84M
-156.97%-4.97M
1,806.60%15.06M
-148.30%-1.14M
Effect of exchange rate changes
-585.85%-112.37K
-118.04%-123.89K
58.18%-114.58K
-80.06%198.07K
-416.69%-191K
-516.90%-16.38K
2,088.15%686.58K
-426.66%-273.95K
892.44%993.56K
-516.67%-36.97K
End cash Position
68.15%30.3M
-48.07%11.66M
-48.07%11.66M
-46.62%14.79M
38.06%16.08M
40.48%18.02M
32.62%22.45M
32.62%22.45M
235.78%27.7M
58.29%11.65M
Free cash from
32.09%-3.25M
35.77%-11.44M
38.93%-3.09M
67.44%-1.57M
45.97%-2M
-12.97%-4.78M
-114.15%-17.81M
-76.92%-5.05M
-138.52%-4.81M
-72.12%-3.7M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 32.09%-3.25M36.49%-11.3M38.93%-3.09M70.28%-1.43M45.90%-2M-13.11%-4.78M-115.07%-17.78M-76.92%-5.05M-138.56%-4.81M-75.10%-3.69M
Net income from continuing operations 50.19%-2.35M-8.01%-22.38M-44.92%-8.61M-23.07%-4.3M24.63%-4.76M5.20%-4.71M-62.83%-20.72M-43.25%-5.94M2.87%-3.5M-131.20%-6.32M
Operating gains losses -1,483.48%-2.27M297.34%5.12M628.50%3.79M153.44%1.02M285.75%142.6K4,273.79%164.03K-8,172.95%-2.6M-1,480.34%-718.02K-1,808.66%-1.91M516.62%36.97K
Depreciation and amortization 10.22%38.31K25.96%145K11.13%38.62K5.39%36.63K2.27%35K205.29%34.75K170.06%115.11K210.14%34.75K219.83%34.75K223.74%34.22K
Remuneration paid in stock 56.28%1.15M117.83%6.04M159.18%1.39M187.55%1.75M160.24%2.16M-7.57%736.78K-30.90%2.77M-50.10%537.12K-53.66%609.53K-1.97%831.2K
Other non cashItems -31.37%2.85K-97.23%14.66K-28.72%3.18K-99.32%3.51K--3.83K--4.15K--528.9K--4.46K--519.37K----
Change In working capital 117.27%174.85K-111.36%-240.35K-71.45%293.54K110.47%59.23K-75.59%419.1K-1,473.59%-1.01M391.28%2.11M581.31%1.03M-258.25%-565.63K857.90%1.72M
-Change in receivables 474.63%236.63K-703.60%-223.18K-43,531.54%-226.88K-76.13%16.78K285.95%50.08K-975.86%-63.16K2,726.07%36.98K97.64%-520326.22%70.3K-4.02%-26.93K
-Change in prepaid assets -145.94%-170.85K123.65%57.32K166.31%182.21K-407.73%-159.67K-519.63%-337.15K472.82%371.94K-314.12%-242.33K-259.54%-274.8K-71.39%51.89K80.75%80.35K
-Change in payables and accrued expense 108.26%109.07K-103.21%-74.49K-74.05%338.21K129.39%202.12K-57.54%706.17K-3,297.88%-1.32M627.98%2.32M186,121.57%1.3M-530.99%-687.81K778.72%1.66M
Cash from discontinued investing activities
Operating cash flow 32.09%-3.25M36.49%-11.3M38.93%-3.09M70.28%-1.43M45.90%-2M-13.11%-4.78M-115.07%-17.78M-76.92%-5.05M-138.56%-4.81M-75.10%-3.69M
Investing cash flow
Cash flow from continuing investing activities 0-557.92%-138.85K1-2,320.19%-138.46K70.54%-2.94K147.27%2.55K53.19%-21.11K0-108.04%-5.72K76.39%-9.99K
Net PPE purchase and sale --085.43%-3.07K--153.17%-2.68K70.54%-2.94K147.27%2.55K-667.73%-21.11K--0-108.04%-5.72K---9.99K
Net intangibles purchas and sale -------135.78K--0--------------0--0--------
Cash from discontinued investing activities
Investing cash flow --0-557.92%-138.85K--1-2,320.19%-138.46K70.54%-2.94K147.27%2.55K53.19%-21.11K--0-108.04%-5.72K76.39%-9.99K
Financing cash flow
Cash flow from continuing financing activities 5,924.01%22M-96.62%766.29K-6.16%74.77K-99.64%72.38K-90.09%253.86K184.63%365.27K15.44%22.64M-99.31%79.68K607.61%19.87M-43.26%2.56M
Net issuance payments of debt 0.00%-25.23K-33.33%-100.93K0.00%-25.23K-0.00%-25.23K0.00%-25.23K---25.23K---75.7K---25.23K---25.23K---25.23K
Net common stock issuance --23.01M--0--0----------04.56%19.76M-99.06%108.35K--------
Proceeds from stock option exercised by employees 58.89%620.46K-71.87%867.21K-20.38%100K-58.51%97.61K-89.24%279.09K204.29%390.51K29.67%3.08M-87.89%125.6K-63.23%235.3K--2.59M
Net other financing activities ---1.6M--------------------92.26%-129.04K------------
Cash from discontinued financing activities
Financing cash flow 5,924.01%22M-96.62%766.29K-6.16%74.77K-99.64%72.38K-90.09%253.86K184.63%365.27K15.44%22.64M-99.31%79.68K607.61%19.87M-43.26%2.56M
Net cash flow
Beginning cash position -48.07%11.66M32.62%22.45M-46.62%14.79M38.06%16.08M40.48%18.02M32.62%22.45M202.38%16.93M235.78%27.7M58.29%11.65M157.25%12.83M
Current changes in cash 524.97%18.76M-320.59%-10.67M39.46%-3.01M-109.93%-1.5M-53.06%-1.75M-7.54%-4.41M-57.20%4.84M-156.97%-4.97M1,806.60%15.06M-148.30%-1.14M
Effect of exchange rate changes -585.85%-112.37K-118.04%-123.89K58.18%-114.58K-80.06%198.07K-416.69%-191K-516.90%-16.38K2,088.15%686.58K-426.66%-273.95K892.44%993.56K-516.67%-36.97K
End cash Position 68.15%30.3M-48.07%11.66M-48.07%11.66M-46.62%14.79M38.06%16.08M40.48%18.02M32.62%22.45M32.62%22.45M235.78%27.7M58.29%11.65M
Free cash from 32.09%-3.25M35.77%-11.44M38.93%-3.09M67.44%-1.57M45.97%-2M-12.97%-4.78M-114.15%-17.81M-76.92%-5.05M-138.52%-4.81M-72.12%-3.7M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg